Key facts
- It has raised $280K; the latest was Seed Round ($280K) in Dec 2025.
- Notable investors include Antler.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Bleep64
- ·The full record, as it builds
Funding rounds
No funding rounds for Bleep64 are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Bleep64
Developer of an AI-based clinical simulation platform designed for medical students to practice patient management and investigation according to UKMLA and NICE guidelines. The company's patient simulator replaces static pattern recognition with dynamic clinical reasoning, enabling clients to bridge the gap between written exams and actual ward practice through infinite and compliant scenarios and personalized weakness tracking.
- Sector
- Information Technology
- HQ
- London, United Kingdom
- Founded
- 2025
- Employees
- 2
- Website
- bleep64.com/
- Ownership
- Privately Held (backing)
Bleep64 doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Bleep64 shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Bleep64 in its N-PORT filings yet. We sweep new filings monthly.